Technology and life sciences specialist early-stage company investment group Deepbridge Capital has launched an Enterprise Investment Scheme (EIS) that aims to exploit the investment manager's knowledge of healthcare and medical technology innovation.
As revealed by Professional Adviser last week, the fund will follow the model of Deepbridge's existing Seed EIS aimed at the same sector. That vehicle has raised £5.2m to date and will have funded more than 30 companies as of the end of this tax year. Deepbridge makes much of its expertise in the life sciences arena and currently manages more than £60m in various funds, including the evergreen Deepbridge Technology Growth EIS. The company pointed out investing in life sciences, healthcare, biotech and medical technology requires sector-specific knowledge. "With life sciences, it is a ...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
